Skip to main navigation Skip to search Skip to main content

SUNY NeuroNEXT: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects with Progressive Multiple Sclerosis #NN102

Project: Research

Project Details

StatusFinished
Effective start/end date05/1/14 → 06/30/18

Funding

  • National Inst of Neurological Disorders & Stroke: $52,220.00